Andrew Koppisch to Humans
This is a "connection" page, showing publications Andrew Koppisch has written about Humans.
Connection Strength
0.066
-
Fox DT, Schmidt EN, Tian H, Dhungana S, Valentine MC, Warrington NV, Phillips PD, Finney KB, Cope EK, Leid JG, Testa CA, Koppisch AT. Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2. PLoS One. 2014; 9(4):e95271.
Score: 0.023
-
Hotta K, Kim CY, Fox DT, Koppisch AT. Siderophore-mediated iron acquisition in Bacillus anthracis and related strains. Microbiology (Reading). 2010 Jul; 156(Pt 7):1918-1925.
Score: 0.017
-
Bardsley TA, Evans CL, Greene JR, Audet R, Harrison MJ, Zimmerman M, Nieto NC, Del Sesto RE, Koppisch AT, Kellar RS. Integration of choline geranate into electrospun protein scaffolds affords antimicrobial activity to biomaterials used for cutaneous wound healing. J Biomed Mater Res B Appl Biomater. 2021 09; 109(9):1271-1282.
Score: 0.009
-
Zakrewsky M, Banerjee A, Apte S, Kern TL, Jones MR, Sesto RE, Koppisch AT, Fox DT, Mitragotri S. Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications. Adv Healthc Mater. 2016 06; 5(11):1282-9.
Score: 0.006
-
Zakrewsky M, Lovejoy KS, Kern TL, Miller TE, Le V, Nagy A, Goumas AM, Iyer RS, Del Sesto RE, Koppisch AT, Fox DT, Mitragotri S. Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization. Proc Natl Acad Sci U S A. 2014 Sep 16; 111(37):13313-8.
Score: 0.006
-
Smith JM, Warrington NV, Vierling RJ, Kuhn ML, Anderson WF, Koppisch AT, Freel Meyers CL. Targeting DXP synthase in human pathogens: enzyme inhibition and antimicrobial activity of butylacetylphosphonate. J Antibiot (Tokyo). 2014 Jan; 67(1):77-83.
Score: 0.005